RecruitingNot ApplicableNCT07662629

Addtional Effect of Hyperbaric Oxygen to Programmed Physical Activity on Musckoloskeletal Pain in Breast Cancer Elderly

Addtion of Hyperbaric Oxygen to Programmed Physical Activity in Aromatse Inhibtors-linked Musckoloskeletal Pain in Breast Cancer Patients


Sponsor

Cairo University

Enrollment

40 participants

Start Date

May 7, 2026

Study Type

INTERVENTIONAL

Conditions

Summary

patienst who survived from breast cancer are prescribed long administraion of aromatase inhbitors.. these inhibitors usually induce musckloskeletal pains. Programmed phsyical activity are reommended to improve these pains but effects of HYperbaric oxygen on these pain was not investigated


Eligibility

Sex: FEMALEMin Age: 65 YearsMax Age: 75 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying exercise and hyperbaric therapy and exercise for people with breast cancer. The study is currently recruiting participants at 1 location. People eligible for this study include women aged 65 Years to 75 Years.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

OTHERhyperbaric therapy and exercise

Twenty elder survivors from breast cancer with musckolskeletal pains resultes from aromatase inhibitor intake received phsyical activity program (aerobci training on traedmill and strengtheining protcol thrice weekly fro 2 month) and additinally received one-hour hyperbaric therapy session , five times weekly for 2 month.

OTHERexercise

Twenty elder survivors from breast cancer with musckolskeletal pains resultes from aromatase inhibitor intake received phsyical activity program (aerobci training on traedmill and strengtheining protcol thrice weekly for 2 month).


Locations(1)

Cairo University

Dokki, Giza Governorate, Egypt

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07662629


Related Trials